Your browser doesn't support javascript.
loading
Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation.
Curley, Paul; Rajoli, Rajith K R; Moss, Darren M; Liptrott, Neill J; Letendre, Scott; Owen, Andrew; Siccardi, Marco.
Affiliation
  • Curley P; Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Rajoli RK; Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Moss DM; Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Liptrott NJ; Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Letendre S; European Nanomedicine Characterisation Laboratory, Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Owen A; Departments of Medicine and Psychiatry, University of California San Diego, San Diego, California, USA.
  • Siccardi M; Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom aowen@liverpool.ac.uk.
Article in En | MEDLINE | ID: mdl-27799216

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Models, Statistical / Anti-HIV Agents / Benzoxazines Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Language: En Journal: Antimicrob Agents Chemother Year: 2017 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Models, Statistical / Anti-HIV Agents / Benzoxazines Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Language: En Journal: Antimicrob Agents Chemother Year: 2017 Type: Article Affiliation country: United kingdom